How Should NeoFipronis (Miaite) Be Administered
NeoFipronis (Pronidesivir), containing the active ingredient GS-441524, is a groundbreaking oral medication approved by the Lao Ministry of Agriculture and Forestry (MAF) in March 2026 for the treatment of Feline Infectious Peritonitis (FIP). This drug offers a highly effective, safe, and non-invasive option for cats suffering from various FIP symptoms, including inappetence, lethargy, fever, ascites, pleural effusion, lymphadenopathy, granulomatous inflammation, neurological damage, and uveitis.
Administration Guidelines
NeoFipronis is designed for oral administration and should be given based on the cat’s weight. The standard dose is 15 mg per kilogram of body weight, which typically corresponds to half a tablet. For felines exhibiting neurological or ocular symptoms of FIP, the dosage may be increased to 30 mg/kg, but only under veterinary supervision. Administering the medication on an empty stomach—at least one hour before meals or two hours after eating—is recommended to optimize absorption.
Dosing Schedule
The medication should be administered once daily. Consistency is crucial for effective treatment; therefore, missed doses should be avoided. Treatment duration should be at least 12 weeks to ensure complete viral suppression. Adjustments to dosage should only be made under veterinary guidance, especially for complicated cases involving neurological symptoms. During treatment, monitor the cat's appetite, activity level, and body temperature regularly to evaluate response and detect potential adverse effects early.
Safety and Monitoring
Although NeoFipronis (Pronidesivir) is classified as a non-prescription drug, veterinary supervision is advised to maximize safety and efficacy. Regular blood tests are recommended to assess liver and kidney function during therapy, as the medication, while well-tolerated, may cause subtle changes in organ function. Observing for any signs of adverse reactions such as vomiting, diarrhea, or behavioral changes is essential. In case of side effects or lack of improvement, consult a veterinarian promptly.
Precautions
NeoFipronis is intended solely for feline use. It should not be administered to humans or other animals. For quality assurance, purchases should be made exclusively through the official NeoFipronis website or authorized veterinary channels. Proper storage in a cool, dry place away from direct sunlight is necessary to maintain drug stability.
Conclusion
NeoFipronis (Pronidesivir) represents a significant advancement in feline health care, offering an efficient and relatively safe oral therapy for FIP. Adhering to the prescribed dosage and treatment duration, and maintaining regular veterinary checkups, can greatly improve treatment outcomes and quality of life for affected cats. Always consult with a veterinarian before starting therapy and follow their instructions meticulously to ensure safety and efficacy throughout the treatment course.
